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Abstract
Background: Small supernumerary marker chromosomes (sSMC) occur in 0.075% of unselected
prenatal and in 0.044% of consecutively studied postnatal cases. Individuals with sSMC present with
varying phenotype, ranging from normal to extremely mild or severe depending on the
chromosomal region involved, the euchromatic content present and degree of mosaicism. Except
for chromosomes 15 and 22, the number of reported cases of sSMC is extremely small to provide
us with a good genotype-phenotype correlation. Analphoid sSMC are even rarer. To our
knowledge only eight cases of analphoid inversion-duplication 3q sSMC are reported so far.
Results: We describe here a one month old female child with several dysmorphic features and
with a de novo analphoid supernumerary marker chromosome only in cultured skin fibroblast cells
and not in lymphocytes. The marker was characterized as analphoid inversion-duplication 3q25.33-
qter by oligo array comparative genomic hybridization (aCGH) and fluorescence in situ
hybridization (FISH) studies. The final skin fibroblast karyotype was interpreted as
47,XX,+der(3).ish inv dup(3)(qter-q25.33::q25.33-qter)(subtel 3q+,subtel 3q+) de novo.
Conclusion:  In addition to the eight reported cases of analphoid inversion-duplication 3q
supernumerary marker in the literature, this is yet another case of 3q sSMC with a new breakpoint
at 3q25.33 and with varying phenotype as described in the case report. Identification of more and
more similar cases of analphoid inversion-duplication 3q marker will help in establishing a better
genotype-phenotype correlation. The study further demonstrates that aCGH in conjunction with
routine cytogenetics and FISH is very useful in precisely identifying and characterizing a marker
chromosome, and more importantly help in providing with an accurate genetic diagnosis and better
counseling to the family.
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Background
Small supernumerary marker chromosomes occur in
0.075% of unselected prenatal cases and in 0.044% of
consecutively studied postnatal cases, and majority of
them are de novo in origin [1-4]. Phenotype of individuals
with de novo sSMC vary from normal to extremely mild or
severe, depending on the chromosomal region involved
and the euchromatic content present [5-7]. Although a
number of reports describe the occurrence of a variety of
sSMC for nearly all the chromosomes, the number for
each type is not large enough to suggest a good genotype-
phenotype correlation for a given sSMC, except for inv
dup(15) and inv dup(22) where the phenotypic conse-
quences are well described [6,8-10]. We describe here the
phenotype and corresponding molecular cytogenetic
results of a child with dysmorphic features. This is yet
another case of analphoid 3q supernumerary marker
chromosome involving a new break point at 3q25.33. The
marker is characterized as inversion-duplication 3q25.33-
qter by oligo aCGH and FISH studies and it also reveals
tissue specific mosaicism.
Case presentation
A one month old female child presenting with several dys-
morphic features was referred to us for cytogenetic studies.
She was the second child of unrelated parents. The first
child was normal. The pregnancy and delivery at term
were normal. Birth weight was 2.2 Kg, length 45 cm and
head circumference was 32 cm. At birth she was noted to
have several dysmorphic features including: prominent
hairy forehead with hair extending up to the cheeks,
upslanting palpebral fissures, depressed nasal bridge with
short nose and very smooth philtrum, thin upper lip
which was turning downward, low set ears, micrognathia,
chubby cheeks, contracture of the fingers with postaxial
polydactyly of left hand, widely separated toes which were
overlapping, streaky pigmentation on the inner aspect of
both fore arms distributed along the lines of Blaschko.
Opthalmological exam was normal. Echocardiography
showed sub-aortic ventricular septal defect (VSD), pulmo-
nary hypertention and moderate valvular pulmonary ste-
nosis. Skeletal survey showed a tiny projection of the tip
of coccyx, a tail-like sacrococcygeal appendage. Computed
tomography scan of the lumbosacral spine showed prom-
inence of coccyx and outward projection. Magnetic reso-
nance imaging of the brain showed partial hypoplasia of
the corpus callosum and slight hypoplasia of the cerebel-
lum.
Results
Cytogenetic study by Giemsa banding (G-banding)
showed normal 46,XX chromosomes in all the 50 lym-
phocyte cells and 47,XX,+mar in all the 70 skin fibroblast
cells studied (Fig. 1a). The marker chromosome was con-
stitutive heterochromatin band (C-band) and nucleolar
organizer region (NOR) staining negative. Fluorescence in
situ hybridization studies using Pan-centromeric alpha-
satellite FISH probe (Cambio) showed no hybridization
onto the marker chromosome (Fig. 1b), confirming it to
be analphoid. Immuno-FISH studies for centromere spe-
cific proteins could not be undertaken to confirm the for-
mation of a neocentromere. However, the fact that the
marker was confirmed as analphoid by FISH and was also
found to be highly stable in skin fibroblast culture,
strongly suggest of a possible neocentromere formation.
Peripheral blood chromosomes of the parents were nor-
mal by G-banding and by all chromosome specific sub-
telomeric FISH analysis. Array-CGH studies on cultured
skin fibroblast cells of the patient showed amplification of
oligo-probes from probe FLJ14153 at 3q25.33 (160.03
Mb) to 3qter (199.29 Mb) (Fig. 2) confirming the origin
and breakpoint of the marker chromosome. The observa-
tion was further validated by FISH studies using chromo-
some 3 specific subtelomere FISH probe (Vysis), which
revealed the marker to be inversion-duplication 3q25.33-
qter (Fig. 1c).
Discussion
Supernumerary marker chromosomes are a cause of great
concern and pose huge challenge in routine medical prac-
tice, particularly in genetic diagnosis and counseling. Pre-
cise identification and complete characterization of the
marker chromosome is very important to understand the
underlying cause of the disease and to establish a good
genotype-phenotype correlation.
Analphoid markers are rare observations, in which the
marker chromosome lacks centromeric alphoid DNA
sequences, that are otherwise typically present in normal
functional centromeres. Survival and stability of such an
analhpoid marker chromosome depends on the forma-
tion of a neocentromere [11]. At present 73 cases of neo-
centromeric sSMC originating from different
chromosomes are reported in the literature, of which 13q,
15q and 3q are the most frequent observations [1]. To our
knowledge only 9 cases of analphoid 3q inversion-dupli-
cation marker (including the present case) are reported so
far, involving chromosomal break points 3q22.3,
3q25.33, 3q26.2, 3q27.1, 3q27.2 and 3q28 [12-19]. A
brief summary of the clinical features, chromosomal
breakpoints and degree of mosaicism of the reported cases
with 3q inversion-duplication supernumerary marker
chromosome is presented in Table 1. As can be seen, the
most frequent break point is at 3q26.2 (4 out of 9 cases)
suggesting that this is possibly the most common site of
neocentromere formation in a 3q marker. However, find-
ings of other break points between 3q22 to 3q28 strongly
suggest that this region probably has several potential
hotspots of necentromere formation.Molecular Cytogenetics 2008, 1:19 http://www.molecularcytogenetics.org/content/1/1/19
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Although all of the above cases with an analphoid 3q
marker chromosome share some common clinical fea-
tures, they still show widely varying phenotypes, probably
due to the presence of varying euchromatic content as well
as varying degree of mosiaicism (Table 1). Except for the
case described by Portnoi et al [17] where the patient pre-
sented only with lines of Blaschko but otherwise healthy
and not dysmorphic, all the other reported cases pre-
sented with developmental delay, severe dysmorphic fea-
tures and multiple congenital anomalies involving several
organs and systems. Our present case with break point at
3q25.33 presented with strikingly distinct phenotype as
described in the case report. The typical facial appearance
and the prominent hairy forehead are distinctive features,
in addition to the cardiac and skeletal abnormalities that
are similar to the cases described by Gimelli et al and
Cockwell et al[12,13].
Mosaicism is reported in 59% of cases where the sSMC are
found in association with a normal cell line [4]. Five of the
nine cases discussed here showed tissue specific mosai-
cism where the 3q marker was present only in fibroblasts
and not in lymphocytes (case number 1–3 and 5–6 of
Table 1), other two cases showed varying degree of mosa-
icism in lymphocytes as well as in fibroblasts (case
number 4 and 7 of Table 1), and the remaining two cases
had the marker chromosome in 71% and 100% lym-
phocytes respectively (case number 8 and 9 of Table 1).
Keeping in mind the specific clinical features of the
patient and with the application of modern molecular
cytogenetic detection methods such as aCGH and FISH,
more and more similar cases are likely to be identified
that would further help in obtaining a better genotype-
phenotype correlation, and in providing with an accurate
genetic diagnosis and better informed counseling, which
is highly valuable to the patients.
a) Partial G-banded metaphase from skin fibroblast cell showing the marker chromosome (arrow) Figure 1
a) Partial G-banded metaphase from skin fibroblast cell showing the marker chromosome (arrow). b) Supernumerary marker 
chromosome showing no hybridization with human alpha-satellite Pan-centromeric probe (Cambio). (c) Chromosome 3 spe-
cific subtelomeric FISH (Mix 3 – Vysis) showing one normal chromosome 3 (3ptel green/3qtel red) and the marker chromo-
some with two red signals for 3q subtelomere, confirming the marker to be inversion-duplication 3q25.33-qter.Molecular Cytogenetics 2008, 1:19 http://www.molecularcytogenetics.org/content/1/1/19
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Methods
Cytogenetic and fish studies
Cytogenetic study was carried out on peripheral blood
lymphocytes by G-banding according to the standard pro-
cedures [20], and 50 G-banded metaphases were ana-
lyzed. FISH study was undertaken using all chromosome
specific sub-telomere FISH probes (Vysis). Hybridization
and washing was done as per manufacturer's protocol and
100 metaphases were analyzed. Due to the strong abnor-
mal clinical presentation and presence of prominent
streaky pigmentation, further studies were undertaken on
cultured skin fibroblast cells by routine G-banding and 70
metaphase spreads were analyzed, followed by C-band
and NOR staining [20]. To further characterize the marker
chromosome, alpha-satellite Pan-centromeric (Cambio)
and chromosome 3 specific sub-telomeric (Vysis) FISH
studies were performed as per manufacturer's instruc-
tions.
Oligo array CGH studies and validation
Oligo aCGH analysis was carried out using Human 44A
microarray (Agilent) to determine the origin of the marker
chromosome and to precisely identify the breakpoint
region involved in the formation of the marker. The array
contained  in situ synthesized 60-mer oligonucleotides
representing a total of 44,290 features. The oligonucle-
otide probes span the human genome with an average
spatial resolution of approximately ~75 Kb, including
coding and non-coding sequences, providing sufficient
coverage for a genome-wide survey of DNA aberrations.
Genomic DNA was extracted from cultured skin fibroblast
cells of the patient by routine Proteinase K method and
co-hybridized with normal male control DNA (Promega).
DNA labelling, hybridization to oligonucleotide-array
and post washing was carried out according to the proto-
col from Agilent Technologies and as described in Murthy
et al [21]. Array CGH result was further validated by FISH
study using chromosome 3 specific subtelomere FISH
probe (Vysis).
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